{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:26:28Z","timestamp":1793622388239,"version":"4.5.0"},"reference-count":67,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Respiratory Medicine"],"published-print":{"date-parts":[[2026,11,2]]},"DOI":"10.1080\/17476348.2026.2729505","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:05:07Z","timestamp":1788451507000},"page":"1263-1275","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Clesrovimab, a monoclonal antibody for the prevention of respiratory syncytial virus disease in infants: a drug profile"],"prefix":"10.1080","volume":"20","author":[{"given":"Margarethe","family":"Wiedenmann","sequence":"first","affiliation":[{"name":"University of the Witwatersrand","place":["Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyaad","family":"Dangor","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand","place":["Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand","place":["Johannesburg, South Africa"]},{"name":"University of the Witwatersrand","place":["Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00478-0"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab159"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2015.04.005"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00414-3"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30721-4"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piae017"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0544-x"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01628-7"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-025-02154-w"},{"issue":"7","key":"e_1_3_5_12_1","first-page":"CD013757","article-title":"Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children","volume":"7","author":"Garegnani L","year":"2025","unstructured":"Garegnani L, Roson Rodriguez P, Escobar Liquitay CM, et al. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database Syst Rev. 2025;7(7):CD013757.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110275"},{"key":"e_1_3_5_14_1","unstructured":"European Medicines Agency (EMA). Summary of product characteristics. 2022 [cited 2026 May 10]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/beyfortus-epar-product-information_en.pdf"},{"key":"e_1_3_5_15_1","unstructured":"US FOOD & DRUG ADMINISTRATION (US FDA). HIGHLIGHTS OF PRESCRIBING INFORMATION - BEYFORTUS (nirsevimab-alip) injection for intramuscular use 2023. [cited 2026 May 10]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761328s005lbl.pdf"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2214773"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7309a4"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70662"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069510"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2216480"},{"key":"e_1_3_5_21_1","unstructured":"European Medicines Agency (EMA). Summary of product characteristics 2023. [cited 2026 May 10]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/abrysvo-epar-product-information_en.pdf"},{"key":"e_1_3_5_22_1","unstructured":"US FOOD & DRUG ADMINISTRATION (US FDA). ABRYSVO\u00ae (respiratory syncytial virus vaccine) for injection for intramuscular use. 2023 [cited 2026 May 10]. Available from: https:\/\/www.fda.gov\/media\/168889\/download?attachment"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00156-2"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00624-3"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40057-8"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12137-1"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae581"},{"key":"e_1_3_5_28_1","unstructured":"US FOOD & DRUG ADMINISTRATION (US FDA). FULL PRESCRIBING INFORMATION - ENFLONSIA\u2122 (clesrovimab-cfor) injection for intramuscular use initial U.S. Approval: 2025. 2025 [cited 2026 Apr 18]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761432s000lbl.pdf"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/87551225251392119"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175792"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae631.2486"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaj1928"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913556"},{"key":"e_1_3_5_34_1","unstructured":"US FOOD & DRUG ADMINISTRATION (US FDA). SYNAGIS\u00ae (PALIVIZUMAB) for intramuscular administration. 1999 [cited 2026 May 10]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2002\/palimed102302lb.pdf"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1234914"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00555-11"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.883"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13290"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103651"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2025.107995"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.70199"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2502984"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2026.2760"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae582"},{"key":"e_1_3_5_45_1","unstructured":"US Centers for Disease Control and Prevention (CDC). Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody and intent for RSV monoclonal antibody receipt United States 2025. [cited 2026 Aug 6]. Available from: https:\/\/www.cdc.gov\/rsvvaxview\/dashboard\/monoclonal-antibody-coverage-infants.html"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7432a3"},{"key":"e_1_3_5_47_1","unstructured":"Advisory Committee on Immunization Practices (ACIP). ACIP evidence to recommendations for use of clesrovimab in infants age <8 months born during or entering their first RSV season 2025. [cited 2026 May 15] Available from: https:\/\/www.cdc.gov\/acip\/evidence-to-recommendations\/clesrovimab-infants.html"},{"key":"e_1_3_5_48_1","unstructured":"Jenco M. Sanofi raising price of RSV immunization nirsevimab 2024. [cited 2026 May 10]. Available from: https:\/\/publications.aap.org\/aapnews\/news\/28657\/Sanofi-raising-price-of-RSV-immunization"},{"key":"e_1_3_5_49_1","unstructured":"European Medicines Agency (EMA). Summary of product characteristics 2026. [cited 2026 May 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/enflonsia-epar-product-information_en.pdf"},{"key":"e_1_3_5_50_1","unstructured":"Enflonsia (clesrovimab-cfor) approved to prevent RSV in newborns and infants [internet]. gov.uk; 2026. Available from: https:\/\/www.gov.uk\/government\/news\/enflonsia-clesrovimab-cfor-approved-to-prevent-rsv-in-newborns-and-infants"},{"key":"e_1_3_5_51_1","unstructured":"Swissmedic (Schweizerisches Heilmittelinstitut). Enflonsia\u00ae Injektionsl\u00f6sung in einer Fertigspritze (Clesrovimabum). 2026 [cited 2026 May 15]. Available from: https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/humanarzneimittel\/authorisations\/new-medicines\/enflonsia-injlsg-clesrovimabum.html"},{"key":"e_1_3_5_52_1","unstructured":"The long-acting therapeutics patents and licences database (LAPaL). Clesrovimab. 2026 [cited 2026 May 18]. Available from: https:\/\/lapal.ch\/formulations\/clesrovimab"},{"key":"e_1_3_5_53_1","unstructured":"Drug and Health Product Portal. Details for: ENFLONSIA 2026. [cited 2026 Aug 6]. Available from: https:\/\/dhpp.hpfb-dgpsa.ca\/dhpp\/resource\/106778"},{"key":"e_1_3_5_54_1","unstructured":"Health Sciences Authority (HSA). Listing of approvals 2026. [cited 2026 Aug 6]. Available from: https:\/\/www.hsa.gov.sg\/therapeutic-products\/registration-of-therapeutic-products\/tools-and-resources\/listing-of-approvals-and-post-registration-actions\/listing-of-approvals\/"},{"key":"e_1_3_5_55_1","unstructured":"Jenco M. Sobi discontinues RSV injection Synagis American Academy of Pediatrics (AAP). 2025 [cited 2026 May 15]. Available from: https:\/\/publications.aap.org\/aapnews\/news\/32817\/Sobi-discontinues-RSV-injection-Synagis"},{"key":"e_1_3_5_56_1","unstructured":"European Medicines Agency (EMA). Summary of product characteristics 2009. [cited 2026 May 10]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/synagis-epar-product-information_en.pdf"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00258-4"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2024.01.003"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2026.2690750"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxag019"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00455-9"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.453"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piad113"},{"key":"e_1_3_5_64_1","unstructured":"World Health Organization (WHO). Weekly epidemiological record - WHO position paper on immunization to protect infants against respiratory syncytial virus disease. 2025 [Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/96ec533a-de56-4e1a-8e01-420afda0b683\/content"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(22)00321-2"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1337614"},{"key":"e_1_3_5_68_1","unstructured":"US FOOD & DRUG ADMINISTRATION (US FDA). 2023 Approval Letter - ABRYSVO (STN 125768). 2023 Available from: https:\/\/www.fda.gov\/media\/171492\/download?attachment"},{"key":"e_1_3_5_69_1","unstructured":"World Health Organization. Extract from report of GACVS meeting of 12\u201314 November 2024 published in the WHO weekly epidemiological record on 7 March 2025. 2025 Available from: https:\/\/www.who.int\/groups\/global-advisory-committee-on-vaccine-safety\/topics\/rsv"}],"container-title":["Expert Review of Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17476348.2026.2729505","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17476348.2026.2729505","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17476348.2026.2729505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:34:22Z","timestamp":1793619262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17476348.2026.2729505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,2]]}},"alternative-id":["10.1080\/17476348.2026.2729505"],"URL":"https:\/\/doi.org\/10.1080\/17476348.2026.2729505","relation":{},"ISSN":["1747-6348","1747-6356"],"issn-type":[{"value":"1747-6348","type":"print"},{"value":"1747-6356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}